Trial · NCT02212015
Adverse events59
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 59
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT increased | Hepatobiliary disorders | Pazopanib + Paclitaxel | 4 | 26 | 12 |
| other | AST increased | Hepatobiliary disorders | Pazopanib + Paclitaxel | 4 | 26 | 12 |
| other | Allergic reation to a drug | Product Issues | Pazopanib + Paclitaxel | 2 | 26 | 2 |
| other | Reduced general condition | General disorders | Pazopanib + Paclitaxel | 2 | 26 | 2 |
| other | Alopecia | Skin and subcutaneous tissue disorders | Pazopanib + Paclitaxel | 8 | 26 | 9 |
| other | Anemia | Blood and lymphatic system disorders | Pazopanib + Paclitaxel | 3 | 26 | 6 |
| other | Inappetance | Musculoskeletal and connective tissue disorders | Pazopanib + Paclitaxel | 4 | 26 | 4 |
| other | Hypertension | Vascular disorders | Pazopanib + Paclitaxel | 12 | 26 | 17 |
| other | Rash | Skin and subcutaneous tissue disorders | Pazopanib + Paclitaxel | 3 | 26 | 3 |
| other | Abdominal pain | Gastrointestinal disorders | Pazopanib + Paclitaxel | 5 | 26 | 6 |
| other | Bilirubin increased | Hepatobiliary disorders | Pazopanib + Paclitaxel | 2 | 26 | 3 |
| other | Diarrhea | Gastrointestinal disorders | Pazopanib + Paclitaxel | 16 | 26 | 29 |
| other | Bronchitis | Respiratory, thoracic and mediastinal disorders | Pazopanib + Paclitaxel | 2 | 26 | 2 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Pazopanib + Paclitaxel | 5 | 26 | 6 |
| other | Dysgeusia | Nervous system disorders | Pazopanib + Paclitaxel | 11 | 26 | 21 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Pazopanib + Paclitaxel | 2 | 26 | 4 |
| other | Insomnia | Psychiatric disorders | Pazopanib + Paclitaxel | 2 | 26 | 2 |
| other | Emesis | Gastrointestinal disorders | Pazopanib + Paclitaxel | 3 | 26 | 8 |
| other | Acute nasopharyngitis | Infections and infestations | Pazopanib + Paclitaxel | 3 | 26 | 3 |
| other | Erysipels | Infections and infestations | Pazopanib + Paclitaxel | 2 | 26 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02212015/events